Short Interest in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Declines By 76.3%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large decrease in short interest in May. As of May 15th, there was short interest totaling 792 shares, a decrease of 76.3% from the April 30th total of 3,341 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 17,047 shares, the days-to-cover ratio is currently 0.0 days.

Invesco Pharmaceuticals ETF Stock Down 0.8%

Shares of PJP traded down $0.86 during trading hours on Friday, hitting $109.63. 4,873 shares of the company were exchanged, compared to its average volume of 35,898. The company has a market cap of $358.49 million, a price-to-earnings ratio of 15.59 and a beta of 0.46. Invesco Pharmaceuticals ETF has a fifty-two week low of $78.77 and a fifty-two week high of $110.81. The firm’s fifty day moving average is $104.90 and its 200 day moving average is $105.55.

Institutional Trading of Invesco Pharmaceuticals ETF

Several large investors have recently bought and sold shares of the business. Fifth Third Bancorp purchased a new position in shares of Invesco Pharmaceuticals ETF in the 1st quarter valued at approximately $36,000. Global Assets Advisory LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF during the 1st quarter valued at about $42,000. IFP Advisors Inc grew its position in shares of Invesco Pharmaceuticals ETF by 31.3% during the 4th quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter valued at about $64,000. Finally, Rockefeller Capital Management L.P. grew its position in shares of Invesco Pharmaceuticals ETF by 20.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after acquiring an additional 209 shares during the period.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.